Alyra Therapeutics, Inc. logo

Alyra Therapeutics, Inc.

Next-generation precision oncology

2-10 employees · est. 2020 · Encinitas, United States

VS
Elixir Pharmaceuticals logo

Elixir Pharmaceuticals

Pioneering the future of metabolic disease treatment by harnessing genetic interactions to combat aging and associated diseases.

est. 1999

Elixir Pharmaceuticals is the older company (2020 vs 1999).

Side-by-Side Comparison

Alyra Therapeutics, Inc. Elixir Pharmaceuticals
Founded
2020 1999 older
Headquarters
Encinitas, United States Not tracked yet
Employees
2-10 Not tracked yet
Industry
Biotechnology Biotechnology, Pharmaceutical
Funding Stage
Not tracked yet Series D
Total Funding
Not tracked yet $98.50M
Funding Rounds
Not tracked yet 4
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Precision Oncology, Protein-Protein Interactions, ALY101, Tumor Growth, Blood Vessel Formation, PAK1 Inhibition, Cancer Treatment, Rare Disease Treatment, Ewing Sarcoma, Neurofibromatosis Type 2, Academic Collaborations, Molecular Medicine, Therapeutic Molecules, Baylor College Of Medicine, Indiana University Pharmaceuticals, Metabolic Disease Treatment, Genetic Interactions, Aging Research, Diabetes Treatment, Obesity Treatment, Drug Discovery, Enzyme Interactions, Age-related Diseases, Medical Innovation
Website
alyratx.com elixirpharm.com
Alyra Therapeutics, Inc. logo

About Alyra Therapeutics, Inc.

Alyra Therapeutics is a biotechnology startup founded in 2020 with a focus on pioneering next-generation precision oncology. The company has developed a platform that centers on creating molecules that disrupt protein–protein interactions (PPIs), specifically targeting the physical contacts between...

Elixir Pharmaceuticals logo

About Elixir Pharmaceuticals

Elixir Pharmaceuticals is a biotechnology and pharmaceutical company founded in 1999 with a mission to revolutionize the treatment of metabolic diseases. Their slogan "Pioneering the future of metabolic disease treatment by harnessing genetic interactions to combat aging and associated diseases" enc...

We will tell you when either one moves

BounceWatch watches Alyra Therapeutics, Inc. and Elixir Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Alyra Therapeutics, In... and Elixir Pharmaceuticals — by email.

Frequently Asked Questions

Alyra Therapeutics, Inc. — Next-generation precision oncology. Elixir Pharmaceuticals — Pioneering the future of metabolic disease treatment by harnessing genetic interactions to combat aging and associated diseases.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Alyra Therapeutics, Inc. has raised undisclosed funding while Elixir Pharmaceuticals has raised $98.50M.
Alyra Therapeutics, Inc. and Elixir Pharmaceuticals operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Alyra Therapeutics, Inc. with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Alyra Therapeutics, Inc. on 12 Sep 2024, and Elixir Pharmaceuticals on 21 Jun 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy